Loading clinical trials...
Loading clinical trials...
A Phase II Study Trastuzumab (NSC 688097) in Her2/Neu Positive Cancer of the Gallbladder or Biliary Tract (NCI 7756)
Conditions
Interventions
trastuzumab
laboratory biomarker analysis
Locations
2
United States
University of Southern California, Norris Comprehensive Cancer Center
Los Angeles, California, United States
The University of Texas (UT) MD Anderson Cancer Center
Houston, Texas, United States
Start Date
May 1, 2007
Primary Completion Date
November 1, 2011
Completion Date
November 1, 2011
Last Updated
August 20, 2019
NCT04693377
NCT06500455
NCT07487883
NCT04654208
NCT05863195
NCT07131007
Lead Sponsor
National Cancer Institute (NCI)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions